{"id":42571,"date":"2019-01-09T18:17:43","date_gmt":"2019-01-09T16:17:43","guid":{"rendered":"https:\/\/newserver.fyb.de\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/"},"modified":"2019-01-09T18:17:43","modified_gmt":"2019-01-09T16:17:43","slug":"fintech-expert-dr-tobias-riethmueller-returns-to-gsk","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/","title":{"rendered":"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK"},"content":{"rendered":"

Munich \u2014 GSK Stock\u00admann<\/strong> can report an important step in the expan\u00adsion of its FinTech and Legal\u00adTech advi\u00adsory prac\u00adtice. On Janu\u00adary 1, 2019, Dr. Tobias Rieth\u00adm\u00fcl\u00adler (39, photo)<\/strong>, one of the experts on digi\u00adtal finan\u00adcing models from the very begin\u00adning, retur\u00adned to GSK Stock\u00admann as Equity Part\u00adner. He worked in GSK\u2019s Frank\u00adfurt office until August 2015, after which he joined Schie\u00adder\u00admair Rechtsanw\u00e4lte.<\/p>\n

Tobias Rieth\u00adm\u00fcl\u00adler is quali\u00adfied as a lawyer and graduate econo\u00admist. He advi\u00adses clients in all phases of corpo\u00adrate deve\u00adlo\u00adp\u00adment on corpo\u00adrate and capi\u00adtal market law issues as well as on corpo\u00adrate and project finan\u00adcing. Tobias Rieth\u00adm\u00fcl\u00adler has parti\u00adcu\u00adlar expe\u00adri\u00adence and exper\u00adtise in the legal struc\u00adtu\u00adring of digi\u00adtal finan\u00adcing plat\u00adforms and stan\u00addar\u00addi\u00adzed issu\u00adance models. Since 2008, he has advi\u00adsed over 40 natio\u00adnal and inter\u00adna\u00adtio\u00adnal digi\u00adtal finan\u00adcing plat\u00adforms on struc\u00adtu\u00adring equity, debt and secu\u00adri\u00adties-based models. In 2015 and 2018, he served as a fede\u00adral expert witness on regu\u00adla\u00adtory propo\u00adsals in this area. His work for finan\u00adcing plat\u00adforms also includes the design of IT proces\u00adses in compli\u00adance with super\u00advi\u00adsory law and the auto\u00adma\u00adtion of data\u00adbase-supported contract processing.<\/p>\n

\u201cWe are very plea\u00adsed about the return of Tobias Rieth\u00adm\u00fcl\u00adler to GSK Stock\u00admann. With his exper\u00adtise in FinTech and Legal\u00adTech, we will be able to signi\u00adfi\u00adcantly broa\u00adden our regu\u00adla\u00adtory and capi\u00adtal markets exper\u00adtise in the area of bank-inde\u00adpen\u00addent finan\u00adcing models,\u201d comm\u00adents Max Wilmanns, spokesper\u00adson of the Corpo\u00adrate prac\u00adtice group at GSK Stock\u00admann. \u201cThere is also enorm\u00adous cross-selling poten\u00adtial with colle\u00adagues from the banking\/finance area, the IT\/data protec\u00adtion colle\u00adagues and the Luxem\u00adbourg office. Finally, Tobias Rieth\u00adm\u00fcl\u00adler can also support us in our own Legal\u00adTech projects.\u201d<\/p>\n

Tobias Rieth\u00adm\u00fcl\u00adler\u2019s advi\u00adsory focus is on the future indus\u00adtries of inte\u00adrest to GSK Stock\u00admann, namely FinTech, in parti\u00adcu\u00adlar digi\u00adtal invest\u00adment brokerage, LegalTech\/Legal Engi\u00adnee\u00adring and PropTech. Due to his inten\u00adsive networ\u00adking in the indus\u00adtry as legal coun\u00adsel of the Bundes\u00adver\u00adband Crowd\u00adfun\u00adding (BVCF) e.V. and foun\u00adding member of the German Crowd\u00adfun\u00adding Network (GCN), Tobias Rieth\u00adm\u00fcl\u00adler is always invol\u00adved in regu\u00adla\u00adtory chan\u00adges and current market deve\u00adlo\u00adp\u00adments. \u201cI am happy to be back at GSK Stock\u00admann and to be able to directly bene\u00adfit from the exper\u00adtise on regu\u00adla\u00adtory issues available at GSK Stock\u00admann,\u201d commen\u00adted Tobias Rieth\u00adm\u00fcl\u00adler. \u201cOver the past three years, I have kept in touch with GSK Stock\u00admann and have always worked with former colle\u00adagues in regu\u00adla\u00adtory law, inclu\u00adding Luxembourg.\u201d<\/p>\n

Through his network, Tobias Rieth\u00adm\u00fcl\u00adler has direct access to inno\u00adva\u00adtive consul\u00adting fields such as crypto asset plat\u00adforms and token issu\u00adan\u00adces. \u201cWe will now be able to imple\u00adment these new areas of advice, which are charac\u00adte\u00adri\u00adzed by ever-incre\u00adasing comple\u00adxity, inter\u00adna\u00adtio\u00adna\u00adlity and digi\u00adta\u00adliza\u00adtion, espe\u00adci\u00adally in the area of regu\u00adla\u00adtory and capi\u00adtal markets law, even better than before,\u201d says Dr. Timo Patrick Bernau, Banking Part\u00adner and FinTech specia\u00adlist at GSK Stockmann.<\/p>\n

For GSK Stock\u00admann, Tobias Rieth\u00adm\u00fcl\u00adler\u2019s addi\u00adtion offers diverse growth poten\u00adtial. This applies in parti\u00adcu\u00adlar to the expan\u00adsion of the network to include new clients who want to bene\u00adfit from the inno\u00adva\u00adtive exper\u00adtise of FinTechs, as well as the increased inclu\u00adsion of secu\u00adri\u00adtiza\u00adtion models and struc\u00adtu\u00adred finance in coope\u00adra\u00adtion with the Luxem\u00adbourg office of GSK Stock\u00admann. The Corpo\u00adrate divi\u00adsion will parti\u00adcu\u00adlarly bene\u00adfit from Tobias Rieth\u00adm\u00fcl\u00adler\u2019s exper\u00adtise in the issu\u00adance of capi\u00adtal market instru\u00adments in the equity, debt and mezza\u00adnine areas and the legal and econo\u00admic struc\u00adtu\u00adring of stan\u00addar\u00addi\u00adzed issu\u00adance models \u2014 also in the venture capi\u00adtal area.<\/p>\n

Dr. Tobias Rieth\u00adm\u00fcl\u00adler brings with him as asso\u00adciate Kath\u00adrin M\u00fcller, a lawyer specia\u00adli\u00adzing in regu\u00adla\u00adtory and capi\u00adtal markets law. With the two addi\u00adti\u00adons, the Corpo\u00adrate prac\u00adtice grows to a total of 20 Equity Part\u00adners, 8 Local Part\u00adners and 32 Associates.<\/p>\n","protected":false},"excerpt":{"rendered":"

Munich \u2014 GSK Stock\u00admann can report an important step in the expan\u00adsion of its FinTech and Legal\u00adTech advi\u00adsory prac\u00adtice. On Janu\u00adary 1, 2019, Dr. Tobias Rieth\u00adm\u00fcl\u00adler (39, photo), one of the experts on digi\u00adtal finan\u00adcing models from the very begin\u00adning, retur\u00adned to GSK Stock\u00admann as Equity Part\u00adner. He worked in GSK\u2019s Frank\u00adfurt office until August [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42581,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1374],"tags":[],"class_list":["post-42571","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-people-en","news-category-people-news"],"yoast_head":"\nFinTech expert Dr. Tobias Riethm\u00fcller returns to GSK - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \u2014 GSK Stock\u00admann can report an important step in the expan\u00adsion of its FinTech and Legal\u00adTech advi\u00adsory prac\u00adtice. On Janu\u00adary 1, 2019, Dr. Tobias Rieth\u00adm\u00fcl\u00adler (39, photo), one of the experts on digi\u00adtal finan\u00adcing models from the very begin\u00adning, retur\u00adned to GSK Stock\u00admann as Equity Part\u00adner. He worked in GSK\u2019s Frank\u00adfurt office until August […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-09T16:17:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"584\" \/>\n\t<meta property=\"og:image:height\" content=\"634\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK\",\"datePublished\":\"2019-01-09T16:17:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\"},\"wordCount\":601,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"PEOPLE\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\",\"url\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\",\"name\":\"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg\",\"datePublished\":\"2019-01-09T16:17:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg\",\"width\":584,\"height\":634},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/","og_locale":"en_US","og_type":"article","og_title":"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK - FYB Financial Yearbook","og_description":"Munich \u2014 GSK Stock\u00admann can report an important step in the expan\u00adsion of its FinTech and Legal\u00adTech advi\u00adsory prac\u00adtice. On Janu\u00adary 1, 2019, Dr. Tobias Rieth\u00adm\u00fcl\u00adler (39, photo), one of the experts on digi\u00adtal finan\u00adcing models from the very begin\u00adning, retur\u00adned to GSK Stock\u00admann as Equity Part\u00adner. He worked in GSK\u2019s Frank\u00adfurt office until August […]","og_url":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2019-01-09T16:17:43+00:00","og_image":[{"width":584,"height":634,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK","datePublished":"2019-01-09T16:17:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/"},"wordCount":601,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg","articleSection":["General","Featured","News","PEOPLE"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/","url":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/","name":"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg","datePublished":"2019-01-09T16:17:43+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/01\/a-riethmueller_5x6-e1547050629779.jpg","width":584,"height":634},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/fintech-expert-dr-tobias-riethmueller-returns-to-gsk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"FinTech expert Dr. Tobias Riethm\u00fcller returns to GSK"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42571"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42571\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42581"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}